Akums Drugs reported a strong start to FY27 with Q1 revenue at ₹1,167 crore, up 13.9% year-on-year. Profit after tax (PAT) jumped 55.4% to ₹101 crore, showing improved profitability and margin expansion.

Akums Drugs Q1 FY27 Results: Strong Growth in Revenue and Profit

Akums Drugs' operating revenue for the quarter ended June 30, 2026, reached ₹1,167 crore, a 13.9% increase from ₹1,024 crore in Q1 FY26. Profit after tax (PAT) surged by 55.4% to ₹101 crore in Q1 FY27, compared to ₹65 crore in the same period last year. Reader Takeaway: Strong revenue growth and expanding margins signal a positive start to the fiscal year, driven by the core CDMO business.

Akums Drugs Q1 FY27 Revenue Surges 13.9% to ₹1,167 Crore, PAT Up 55.4%

Akums Drugs Q1 FY27 Results: Strong Growth in Revenue and Profit